US Court Rules In Favor Of Viatris For Interchangeable Semglee

Partners Biocon and Viatris To Continue To Market Insulin Glargine Biosimilar

 
• By Akriti Seth
  
Court Ruling
Sanofi loses to Viatris as US Court finds challenged claims unpatentable • Source: Alamy

More from Biosimilars

More from Products